12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Friday's intraday session, several healthcare stocks experienced significant movements. Notably, Better Therapeutics (BTTX) surged by 65.4%, while SELLAS Life Sciences Gr (SLS) dropped by 28.7%. Other notable gainers include Carmell (CTCX) and P3 Health Partners (PIII), with increases of 38.52% and 38.23% respectively. On the losing end, Immuneering (IMRX) and Lucy Scientific Discovery (LSDI) saw declines of 28.45% and 25.64%. These movements reflect the volatile nature of healthcare stocks in the market.
March 15, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Better Therapeutics surged 65.4%, indicating strong investor interest or positive developments.
The significant surge in BTTX's stock price could be due to positive news or investor speculation about its future prospects.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Carmell rose 38.52%, reflecting positive investor sentiment or favorable company developments.
Carmell's significant stock price increase could be attributed to optimistic investor sentiment or positive news related to the company.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
P3 Health Partners saw a 38.23% increase, likely driven by investor optimism or positive company news.
The rise in PIII's stock price may be due to favorable investor perception or encouraging developments within the company.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Immuneering fell 28.45%, indicating potential negative developments or market reactions.
The decrease in IMRX's stock price could reflect adverse news or negative market sentiment towards the company.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
Lucy Scientific Discovery dropped 25.64%, possibly due to unfavorable news or investor sentiment.
The significant drop in LSDI's stock price suggests negative investor sentiment or potentially negative developments affecting the company.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
SELLAS Life Sciences Gr experienced a 28.7% drop, possibly due to negative news or market reactions.
The decline in SLS's stock price suggests negative market sentiment or potentially unfavorable news affecting the company.
CONFIDENCE 75
IMPORTANCE 80
RELEVANCE 90